Dr. Stacie Bingaman, MD (she/her) is an Endocrinologist in Arlington, TX with over 15 years of experience. What is your opinion of Dr. Stacie Bingaman, MD? Rate this provider below so other people can make informed decision.
Over 15 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Stacie Bingaman, MD has received over $16,632 which includes payments from the following companies:
$13,869.96 from sanofi-aventis U.S. LLC
$388.13 from Novo Nordisk Inc
$210.41 from Takeda Pharmaceuticals America, Inc.
$205.54 from Amgen Inc.
$172.26 from Janssen Pharmaceuticals, Inc
$164.35 from AstraZeneca Pharmaceuticals LP
$139.13 from LILLY USA, LLC
$130.02 from NPS Pharmaceuticals, Inc.
$111.14 from Abbott Laboratories
$100.00 from Genentech, Inc.
$96.42 from Shire North American Group Inc
$88.34 from Valeritas, Inc.
$70.93 from GlaxoSmithKline, LLC.
$69.08 from MannKind Corporation
$68.12 from Tandem Diabetes Care, Inc.
$65.15 from Medtronic Sofamor Danek USA, Inc.
$60.00 from Bayer HealthCare Pharmaceuticals Inc.
$50.93 from Novartis Pharmaceuticals Corporation
$50.40 from Roche Diagnostics Corporation
$38.01 from Animas Corporation
Payments received by Dr. Stacie Bingaman, MD were from the following categories:
$10,570.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!